
Boutique venture capital firm funding early-stage disruptive technology companies and mentoring their founders

German investment holding backing life science and health companies developing new therapies and diagnostics

dievini Hopp Biotech Holding invests in life science and health science companies and supports their management teams as they build the business. Its investments centre on new therapy and diagnostic approaches that could open entirely new forms of treatment. The aim is to give doctors and patients therapies that work better and are better tolerated, mostly for life-threatening conditions.
Companies focused on oncology first, plus neurology, infectious disease, cell therapy and improved drug formulation. The geographic focus is Germany and Europe.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about dievini Hopp Biotech Holding.
Similar listings buyers compare against this one.

Boutique venture capital firm funding early-stage disruptive technology companies and mentoring their founders

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Seattle venture firm investing in cancer biotechnology and established technology companies

Venture firm investing in Greek information and communication technology start-ups aimed at global markets

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication
Everything here links back to the same verified catalogue. Pick your next stop.